Share Forum - Discuss JSE shares and join the Investor Challenge

Any ideas why this is continually slipping, currently below R300.00 with volumn of around 2.8 mil in shares?

The main reason - currency. R has strengthened over the past year against major trading currencies. Only recently has it weakened considerably against the Euro, but is still
stronger against eg. the Brazilian Real.
Have patience - one of the best shares on the JSE.

Currency volatility has weighed on the results of the past year. The Group remains exposed to the strength of the US

Dollar against its primary trading currencies.

Best read the financial results for the year ended 30/06/2015

Chris Gilmour on the results ..

CHRIS GILMOUR: That’s quite right. Look, this set of results I actually think is a very good set of results, frankly. I have to disclose we do hold Aspen as a core holding on behalf of our clients. It’s a great operation, it’s really incredibly well run, and I think what you’ve got to do with this set of results is you’ve got to try and distinguish between the operational side – which was very, very good indeed in virtually every jurisdiction in which they operate, including Australia, including the CIS, Russia basically, and Latin America – and, Stephen Saad touched on this, the currencies. Let’s take Australia as a classic example. They are heavily invested in Australia and the Australian dollar has been very, very weak against the US dollar. And the same goes for the Brazilian real, for example. So yes, you can do a bit at the margin in terms of hedging and the like but nevertheless, from a currency perspective, the company has taken a real hit.

Over the reporting period the R has strengthened against Aspen's main trading currencies, Euro, Aussie $, Brazilian Real, Russian Rubel. Their input costs are mainly in US$ which has strengthened against the R quite substantially over the reporting period being the 6 months to 30/06/2015.

Mmm ok will digest. Thanks.

So would you say this is the dip to buy, or is there further downside to this?

Btw, not selling im in for the very long run.

If you are in for the long run, just hold. Having retreated this far the share is looking pretty attractive should you want to add.

South Africa has set up a state-owned pharmaceutical company that would compete with local firms in supplying medicines to public hospitals, President Jacob Zuma said in his state of the nation address on Thursday.

My concern is, that they will lose some contracts due to BEE, but they are a good company.

CAPE TOWN, Feb 11 (Reuters) – South Africa has set up a state-owned pharmaceutical company that would compete with local firms in supplying medicines to public hospitals, President Jacob Zuma said in his state of the nation address on Thursday.

Health authorities in one of the world’s biggest market for antiretroviral drugs have long complained they were paying too much to secure supplies for life-prolonging HIV/AIDS drugs to state-run hospitals.

++++++++++++++++++++++++++++++

I don't think that will impact much at all. The bulk of revenue is derived outside ZA.

A little bit old, but still a good buy....

what's going on with APN - down about 13% this year so far

Speculation..

Release Date: 09/01/2018 14:54:00      Code(s): APN     Email this JSE Sens Item to a Friend   Printer Friendly Version
Market Speculation on Viceroy Research Report

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Group")


MARKET SPECULATION ON VICEROY RESEARCH REPORT

Aspen has become aware that there is market speculation regarding a possible report into Aspen
being undertaken by Viceroy Research, a research group which published an exposé on Steinhoff
recently. Aspen shareholders are advised that it has had no contact with Viceroy Research and, as
such, is unable to confirm that this speculation is correct. Aspen furthermore advises that it is not
aware of any information of a price sensitive nature that requires communication to shareholders and
that trading in the current financial year has been consistent with the prospects communicated to
shareholders in the 2017 financial year results announcement as published on SENS on 14
September 2017.



 Durban
 9 January 2018